One of the most exciting areas of innovation in the biotech sector in recent years has been the development of novel gene-delivery vehicles used in cell- and gene-based therapies. However, … Continued
Interdisciplinary research lies at the heart of Northwestern University’s research ethos. At the Center for Synthetic Biology, a deliberate effort to foster collaboration between various disciplines has led to the … Continued
Pearl Bio was spun out of research from Farren Isaacs, Ph.D., and Michael Jewett, Ph.D., that centers on using ”genomically recoded organisms” to add synthetic chemistry to biologics.
Combatting drug resistance, making biomanufacturing more sustainable and developing more versatile drug delivery vehicles are just a few of the ambitious projects led by Northwestern McCormick School of Engineering graduate … Continued
New technique made human T-cells 100 times more potent at killing cancer cells.
New findings explain how soil sequesters plant-based carbon from the atmosphere
Study marks critical step in creating new therapies to treat antibiotic-resistant infections
New Farley Center course leverages case studies and expert guest speakers to explore commercial innovation in the fast-moving synthetic biology industry.
Northwestern University synthetic biologists have developed a flexible new platform that removes barriers for promising cell and gene therapies.
Translating exciting discoveries into next-generation technologies fuels the mission of the Center for Synthetic Biology (CSB) at Northwestern. Since its inception in 2016, the CSB has produced several start-up companies … Continued
